Microinvasive Glaucoma Surgery in Children

Data are still needed to validate its use.

By Sara J. Coulon, MD, Ta Chen Peter Chang, MD

Update on Suprachoroidal Drainage Devices

Preliminary results from studies of these devices are encouraging.

By Nariman Nassiri, MD, MPH, Brian A. Francis, MD, MS

An Overview of Tonometry Devices

Consider a variety of factors when choosing the right device for your practice.

By Pujan Dave, MD, Thomas V. Johnson, MD, PhD

Laser Trabeculoplasty in the Treatment of Open-angle Glaucoma

Micropulse and selective laser trabeculoplasty are safe and effective first-line treatments.

By Matthew Hirabayashi, MD, Jella An, MD

Management of Glaucoma Following Cataract Surgery in Children

A multifaceted approach leads to best outcomes.

By Hamed Esfandiari, MD

What to Expect for MIGS Reimbursement in 2022

Consider recent changes in the context of the evolution of MIGS.

By Nathan M. Radcliffe, MD

From the Editor: Why Glaucoma Is the Best Ophthalmology Field

By Nathan M. Radcliffe, MD

Patients Are Asking: Can I Use Medical Marijuana to Treat My Glaucoma?

Providers still should counsel patients against using marijuana for this purpose.

By Zachary Bergman, MD, Omolola Idowu, MBChB, Mona Kaleem, MD

Patient Handout: The Facts on Glaucoma Treatment and Marijuana

By John P. Douglas, BS, Zachary Bergman, MD, Omolola Idowu, MBChB, et al.

Coding: When to Bundle or Unbundle Services

Ophthalmologists often provide services for which there is coverage but no separate payment.

By Kevin J. Corcoran, COE, CPC, CPMA, FNAO

Case Files: When Drops Drop the Ball

Sustained delivery is a logical next step.

By Caroline Wilson, MD

Product Spotlight: Medical Food Packs a Big Punch

Guardion's Glaucocetin contains key ingredients to help glaucoma patients.

By Karen Appold, contributing writer

Sight Sciences Launches Glaucoma Awareness Campaign for Optometrists

By Jennifer Ford, senior managing editor

iStent Inject Safe, Effective as Standalone Treatment or With Cataract Surgery

By Conni Koury, contributing editor

Fixed-Combo Dorzolamide-Timolol Dosed 3 Times Daily Superior to, as Safe as BID

By Conni Koury, contributing editor

TearClear Files IND for Its Latanoprost Solution

By Conni Koury, contributing editor

Glaucoma Surgery Significantly Increases Mortality From All Causes: Study

By Conni Koury, contributing editor

Visus Expands Ophthalmic Drug Portfolio; Secures Exclusive License for Drug-delivery Technology

By Conni Koury, contributing editor

Study Reveals How Noninvasive Ocular Diagnostics Can Dispel Pathogen-laden Droplets

By Conni Koury, contributing editor